期刊文献+

利用Deauville 5分法及△SUV法评估滤泡性淋巴瘤预后 被引量:1

Prognostic value of Deauville 5-point scale and △SUV in follicular lymphoma
在线阅读 下载PDF
导出
摘要 目的:比较Deauville 5分法及△SUV法在化疗中期滤泡性淋巴瘤(follicular lymphoma,FL)患者预后评估中的作用。方法:回顾性分析2009年5月至2017年3月病理确诊为FL的患者共22例,其中男性10例,女性12例,年龄22~88(中位年龄56)岁。患者化疗前、4程化疗后均行18F-FDG PET/CT显像。以Deauville评分4分为界点分成2组,行组间Kaplan-Meier生存分析。分别计算治疗前后SUVmax的差值(△SUVmax)及SUVmax下降百分比(△SUVmax%),ROC曲线计算最佳临界值并分组,行组间Kaplan-Meier生存分析。结果:Deauville评分<4分组较Deauville评分≥4分组2年无进展生存期(progress free survival,PFS)明显延长,且有统计学差异(P=0. 000)。22例患者进展12例(12/22,54. 5%),无进展10例(10/22,45. 5%)。进展组与无进展组△SUVmax分别为2. 8±3. 4、6. 9±2. 6,两者有统计学差异(P=0. 005);进展组与无进展组△SUVmax%分别为(29. 9±0. 35)%、(80. 6±0. 09)%,两者有统计学差异(P=0. 001)。结论:Deauville 5分法在中期化疗后评分对于预测FL患者预后有一定价值。 Objective:We aimed to investigate the prognostic value of Deauville 5-point scale(5PS) and △SUV in follicular lymphoma(FL).Methods:22 FL patients[10 males,12 females.Median age:56(22~88)years old]were retrospectively analyzed from May 2009 to March 2017,who had analyzable 18 F-FDG PET/CT scans performed before and after 4 courses of chemotheraphy.Survival functions were estimated by Kaplan-Meier method between patients with Deauville 5-point scale<4 and patients with Deauville 5-point scale≥4.ROC curves were used for determining the best cutoff value of △SUV max and △SUV max%in predicting progress free survival(PFS).Results:When applying the Deauville 5-point scale with a cutoff<4,the 24-month PFS was significantly longer than those applying a cutoff≥4(P=0.000).12 patients(12/22,54.5%)resulted disease progressed within 2 years follow-up,while 10 patients(10/22,45.5%)didn't result disease progressed.The mean values of△SUV max were 2.8±3.4 and 6.9±2.6 in progressed group and non-progressed group(P=0.005).The mean values of△SUV max%disease progressed were(29.9±0.35)%and(80.6±0.09)%in progressed group and non-progressed group(P=0.001).Conclusion:Deauville 5-point scale could assess prognostic value in FL patients after medium-term chemotherapy.
作者 韩磊 赵晋华 陈香 Han Lei;Zhao Jinhua;Chen Xiang(Department of Nuclear Medicine,Shanghai General Hospital of Shanghai Jiaotong University,Shanghai 200080,China)
出处 《现代肿瘤医学》 CAS 2019年第3期477-480,共4页 Journal of Modern Oncology
关键词 滤泡性淋巴瘤 体层摄影术 发射型计算机 X线计算机 脱氧葡萄糖 预后 follicular lymphoma tomography emission-computed X-ray computed deoxyglucose prognosis
  • 相关文献

参考文献3

二级参考文献15

  • 1Cheson BD, Pfistner B, Juweid ME, et al. Revised response crite- ria for malignant lymphoma[ J], J Clin Oneol, 2007, 25(5) : 579- 586. DOI: 10.1200/JCO.2006.09.2403.
  • 2Cheson BD. Role of functional imaging in the management of lym- phoma[J]. J Clin Oneol, 2011, 29(14): 1844-1854. DOI: 10. 1200/JC O. 2010.32.5225.
  • 3Vails L, Badve C, Avril S, et al. FDG-PET imaging in hematologi- cal malignancies [ J ]. Blood Rev, 2016, 30 (4) : 317-331. DOI : 10. lO16/j.hlre.2016.02.003.
  • 4National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oneology: Hodgkin' s Lymphomas (v.2.2016) [ R/ OL]. https ://www. necn. org/professionals/physician _gls/f_guide- lines.asp.
  • 5National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Non-Hodgkin's Lymphomas (v. 2.2016) [ R/OL]. https://www, nccn. org/professionals/physician_gls/f_ guidelines, asp.
  • 6Cheson BD, Fisher RI, Barrington SF, et al. Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification[ J]. J Clin Oncol, 2014, 32(27) : 3059-3068. DOI : 10.1200/JCO.2013.54.8800.
  • 7Seam P, Juweid ME, Cheson BD. The role of FDG-PET scans in patients with lymphoma[J]. Blood, 2007, 110(10) : 3507-3516. DOI: 10.1182/blood-2007 -06-097238.
  • 8Kostakoglu L, Cheson BD. Current role of FDG PET/CT in lympho-ma[J]. Eur J Nucl Med Mol Imaging, 2014, 41(5) : 1004-1027. DOI : 10.1007/s00259-013-2686-2.
  • 9Zinzani PL, Stefoni V, Tani M, et al. Role of [ JSF] fluorodeox- yglucose positron emission tomography scan in the follow-up of lym- phoma[J]. J Clin Oncol, 2009, 27(11): 1781-1787. DOI:10. 1200/JCO.2008.16.1513.
  • 10Petrausch U, Samaras P, Haile SR, et al. Risk-adapted FDG- PET/CT-based follow-up in patients with diffuse large B-cell lym- phoma after first-line therapy [ J ]. Ann Oncol, 2010, 21 (8) : 1694-1698.

共引文献63

同被引文献1

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部